IL-21 gene polymorphisms have been reported to be associated with an increasing number of autoimmune or immunological diseases, including systemic lupus erythematosus (SLE) (27), rheumatoid arthritis (28,29), GD (8) and type 1 diabetes (30). This evidence concerns the gene IL21 and type 1 diabetes mellitus.